THE EFFECT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CARDIOVASCULAR SYSTEM
DOI:
https://doi.org/10.30890/2709-2313.2025-37-02-002Keywords:
arterial hypertension, obesity, dyslipidemia, endothelial function, free-3 polyunsaturated fatty acidsAbstract
Hypertriglyceridemia is a characteristic feature of dyslipidemia in hypertension in patients with concomitant abdominal obesity. These individuals constitute an increased risk of cardiovascular complications, so optimizing their treatment is extremely impMetrics
References
Aktaa S, Gencer B, Arbelo E, et al. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2022;29(7):1060-1071.
Belardo D, Michos ED, Blankstein R, et al. Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement. Am J Prev Cardiol. 2022;10:100323.
Bercea C, Limbu R, Behnam K, et al. Omega-3 polyunsaturated fatty acid-induced vasodilation in mouse aorta and mesenteric arteries is not mediated by ATP-sensitive potassium channels. Front Physiol. 2022;13:1033216.
Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease. Bracewell NJ, Plasschaert J, Conti CR, Keeley EC, Conti JB. Clin Cardiol. 2022 Nov;45(11):1128-1134.
Zhang X, Ritonja JA, Zhou N, Chen BE, Li X. Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2022;11(11):e025071.
Elagizi A, Lavie CJ, O'Keefe E, Marshall K, O'Keefe JH, Milani RV. An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health. Nutrients. 2021;13(1):204.
Yokoyama, M.; Origasa, H.; Matsuzaki, M.; Matsuzawa, Y.; Saito, Y.; Ishikawa, Y.; Oikawa, S.; Sasaki, J.; Hishida, H.; Itakura, H.; et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007, 369, 1090–1098.
Marchioli, R. Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999, 354, 447–455.
Sayah N, Bhatt DL, Miller M, et al. Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024;45(13):1173-1176.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
